Barley is rich in fermentable dietary fiber and phenolic compounds, both of which have recognized benefits for gut health and whose functionality is influenced by processing. Here, four barley genotypes differing in β-glucan content, type of starch, and phenolic profiles were extruded to obtain ready-to-eat products, which were then evaluated using a combined in vitro digestion–colonic fermentation model. The gastrointestinal fate of β-glucans and phenolics, short-chain fatty acids production, phenolic metabolite formation, and gut microbiota composition were assessed. After digestion, substantial amounts of β-glucans and phenolics remained in the non-bioaccessible fraction, supporting their relevance as substrates for colonic fermentation. During fermentation, the β-glucan-rich genotypes Annapurna® and Hilose® showed the strongest butyrogenic response, while the purple-grain genotype DHL-151340, characterized by a flavone- and anthocyanin-rich profile, showed an earlier and more pronounced accumulation of low-molecular-weight phenolic catabolites. Compared with the control, barley extrudates induced time-dependent shifts in microbiota composition, although community profiles tended to converge at later fermentation stages. Overall, genotype- and processing-driven differences translated into distinct fermentation and phenolic biotransformation footprints, highlighting the relevance of barley matrix composition in shaping the colonic fate of cereal bioactive compounds.
Background and Objectives: Anthocyanin-rich barley varieties have recently gained attention due to their high (poly)phenolic content and potential health benefits, yet human data on their bioavailability remain scarce. This study aimed to characterize the absorption, metabolism, and excretion of (poly)phenolic compounds from a novel hull-less purple whole-grain barley (WGB) genotype. Methods: Eleven healthy volunteers consumed 140 g of purple WGB biscuits, and plasma and urine samples were collected over 6 h and 48 h, respectively. Results: UPLC-MS/MS analysis revealed a broad range of metabolites, with 11 (poly)phenolic compounds identified in plasma and 80 in urine. The biscuits were particularly rich in flavones (217 mg/140 g, mainly chrysoeriol derivatives), followed by hydroxycinnamic acids (~54 mg, mainly 4′-hydroxy-3′-methoxycinnamic acid), anthocyanins (44.8 mg), and flavan-3-ols (16.8 mg). In plasma, glycosylated anthocyanins and flavone conjugates (e.g., peonidin-3-O-glucuronide, chrysoeriol-O-glucuronide) were detectable within 1–2 h, consistent with early absorption. In contrast, microbial-derived catabolites—including valerolactones, phenylacetic and benzoic acids—were mainly excreted in urine between 8 and 24 h, reaching concentrations above 1000 nM. Conclusions: These findings provide novel insights into the bioavailability and metabolic fate of barley (poly)phenols, supporting their potential contribution to host and gut health. As a proof-of-concept study, it complements the limited data available from pigmented cereals and underscores the need for validation in larger cohorts.
Anthocyanin-rich barley varieties have recently gained attention due to their high (poly)phenolic content and potential health benefits, yet human data on their bioavailability remain scarce. This study aimed to characterize the absorption, metabolism, and excretion of (poly)phenolic compounds from a novel hull-less purple whole-grain barley (WGB) genotype. Eleven healthy volunteers consumed 140 g of purple WGB biscuits, and plasma and urine samples were collected over 6 h and 48 h, respectively. UPLC-MS/MS analysis revealed a broad range of metabolites, with 11 compounds identified in plasma and 80 in urine. The biscuits were particularly rich in flavones (217 mg/140 g, mainly chrysoeriol derivatives), followed by hydroxycinnamic acids (~54 mg, mainly 4’-hydroxy-3’-methoxycinnamic acid), anthocyanins (44.8 mg), and flavan-3-ols (16.8 mg). In plasma, early absorption of glycosylated anthocyanins and flavone conjugates (e.g., peonidin-3-O-glucuronide, chrysoeriol-O-glucuronide) were observed within 1–2 h. In contrast, microbial-derived catabolites —including valerolactones, phenylacetic and benzoic acids —were mainly excreted in urine between 8 and 24 h, reaching concentrations above 1000 nM. These findings provide novel insights into the bioavailability and metabolic fate of barley (poly)phenols, supporting their potential contribution to host and gut health.